IL33 and graft versus host disease: Soluble ST2 acts as a decoy receptor for interleukin-33 and drives T helper 2 cells toward a type 1 helper T cell phenotype, which may be important in the pathophysiology of GVHD.It is arguable that ST2 monitoring in AHSCT might identify these patients and prevent them from developing acute GVHD.